Ledyard National Bank Abbott Laboratories Transaction History

Ledyard National Bank

  • $1.09 Billion
  • Q3 2024

A detailed history of Ledyard National Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Ledyard National Bank holds 19,079 shares of ABT stock, worth $2.35 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
19,079
Previous 19,610 2.71%
Holding current value
$2.35 Million
Previous $2.04 Million 6.77%
% of portfolio
0.2%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
SELL
$100.07 - $118.13 $53,137 - $62,727
-531 Reduced 2.71%
19,079 $2.18 Million
Q2 2024

Aug 05, 2024
SELL
$100.73 - $112.44 $96,499 - $107,717
-958 Reduced 4.66%
19,610 $2.04 Million
Q1 2024

May 08, 2024
SELL
$109.52 - $120.96 $142,704 - $157,610
-1,303 Reduced 5.96%
20,568 $2.34 Million
Q4 2023

Feb 05, 2024
BUY
$90.19 - $110.4 $205,452 - $251,491
2,278 Added 11.63%
21,871 $2.41 Million
Q3 2023

Nov 07, 2023
SELL
$95.53 - $114.62 $2,197 - $2,636
-23 Reduced 0.12%
19,593 $1.9 Million
Q2 2023

Aug 09, 2023
SELL
$100.78 - $112.29 $27,512 - $30,655
-273 Reduced 1.37%
19,616 $2.14 Million
Q1 2023

Apr 25, 2023
SELL
$96.86 - $114.01 $27,605 - $32,492
-285 Reduced 1.41%
19,889 $2.01 Million
Q4 2022

Feb 06, 2023
SELL
$95.06 - $111.52 $73,861 - $86,651
-777 Reduced 3.71%
20,174 $2.22 Million
Q3 2022

Oct 18, 2022
SELL
$96.76 - $112.03 $9,869 - $11,427
-102 Reduced 0.48%
20,951 $2.03 Million
Q2 2022

Jul 19, 2022
SELL
$102.07 - $123.37 $70,530 - $85,248
-691 Reduced 3.18%
21,053 $2.29 Million
Q1 2022

Apr 25, 2022
SELL
$114.02 - $139.04 $124,965 - $152,387
-1,096 Reduced 4.8%
21,744 $2.57 Million
Q4 2021

Jan 31, 2022
SELL
$115.53 - $141.46 $306,501 - $375,293
-2,653 Reduced 10.41%
22,840 $3.21 Million
Q3 2021

Oct 20, 2021
SELL
$116.66 - $129.06 $319,765 - $353,753
-2,741 Reduced 9.71%
25,493 $3.01 Million
Q2 2021

Jul 27, 2021
SELL
$105.79 - $124.53 $67,705 - $79,699
-640 Reduced 2.22%
28,234 $3.27 Million
Q1 2021

Apr 27, 2021
BUY
$108.84 - $128.23 $299,201 - $352,504
2,749 Added 10.52%
28,874 $3.46 Million
Q4 2020

Jan 25, 2021
SELL
$105.0 - $114.42 $66,045 - $71,970
-629 Reduced 2.35%
26,125 $2.86 Million
Q3 2020

Oct 21, 2020
SELL
$91.64 - $111.29 $68,271 - $82,911
-745 Reduced 2.71%
26,754 $2.91 Million
Q2 2020

Jul 24, 2020
SELL
$76.57 - $98.0 $45,252 - $57,918
-591 Reduced 2.1%
27,499 $2.51 Million
Q1 2020

Apr 24, 2020
SELL
$62.82 - $91.86 $31,975 - $46,756
-509 Reduced 1.78%
28,090 $2.22 Million
Q4 2019

Jan 31, 2020
SELL
$78.51 - $87.4 $51,659 - $57,509
-658 Reduced 2.25%
28,599 $2.48 Million
Q3 2019

Oct 23, 2019
SELL
$81.84 - $88.74 $80,694 - $87,497
-986 Reduced 3.26%
29,257 $2.45 Million
Q2 2019

Jul 26, 2019
SELL
$72.88 - $85.0 $125,936 - $146,880
-1,728 Reduced 5.4%
30,243 $2.54 Million
Q1 2019

Apr 12, 2019
SELL
$66.22 - $80.06 $579,623 - $700,765
-8,753 Reduced 21.49%
31,971 $2.56 Million
Q4 2018

Jan 29, 2019
SELL
$65.56 - $74.27 $47,989 - $54,365
-732 Reduced 1.77%
40,724 $2.95 Million
Q3 2018

Oct 24, 2018
BUY
$60.81 - $73.36 $608 - $733
10 Added 0.02%
41,456 $3.04 Million
Q2 2018

Jul 11, 2018
SELL
$57.57 - $63.54 $54,691 - $60,363
-950 Reduced 2.24%
41,446 $2.53 Million
Q1 2018

Apr 16, 2018
SELL
$56.27 - $63.62 $797,852 - $902,067
-14,179 Reduced 25.06%
42,396 $2.54 Million
Q4 2017

Jan 30, 2018
BUY
$53.68 - $57.47 $5,206 - $5,574
97 Added 0.17%
56,575 $3.23 Million
Q3 2017

Oct 10, 2017
BUY
$48.06 - $53.64 $2.71 Million - $3.03 Million
56,478
56,478 $3.01 Million

Others Institutions Holding ABT

# of Institutions
3,204
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $216B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ledyard National Bank Portfolio

Follow Ledyard National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Ledyard National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email